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Natriuretic and sodium transport inhibitory activity in plasma of
volume-expanded dogs. (Jitrafiltrates of jugular vein plasma from
dogs acutely expanded with saline caused a 25 3.1 % (mean
saM) inhibition of toad bladder short circuit current (SCC).
Similar ultrafiltrates obtained from dogs acutely volume-
depleted following furosemide administration caused a change
of 3 I .7% in SCC (P <0.001). Plasma ultrafiltrates of volume-
expanded dogs also inhibited SCC of the frog skin. SCC inhibi-
tion was not due to blood dilution with saline. Antinatriferic
activity passed readily through a permselective membrane with a
molecular weight cutoff of 500. On Sephadex G-10 column
chromatography, antinatriferic activity was confined to a single
fraction with a molecular weight less than 700. The same fraction
which inhibited 5CC caused an increase in sodium excretion and
urine volume in partially nephrectomized rats undergoing a
maximum water diuresis. These results indicate that plasma of
volume-expanded dogs contains a humoral factor with a molecu-
lar weight less than 500 to 700 which inhibits sodium transport
in vitro and causes natriuresis in vivo. This factor could modulate
renal sodium excretion under some physiologic conditions.
Activité natriurétique et inhibitrice du transport de sodium dans
Ic plasma de chiens ayant subi une expansion de liquides extra-
cellulaires. Des ultrafiltrats de plasma de sang jugulaire de chiens
ayant subi une expansion aiguë avec du salin physiologique
determinant une diminution du courant de court-circuit (SCC)
de 25 3,1 % (at saM). Des ultrafiltrats semblables, mais
obtenus a partir de chiens ayant subi une déplétion par la
furosémide ont déterminé une modification de 3± 1 ,7% de
5CC (P<0,00l). Des ultrafiltrats de chiens ayant subi une
expansion ont aussi inhibé le 5CC de Ia peau de grenouille.
L'inhibition du SCC n'est pas due a la dilution de sang par Ia
solution physiologique. L'activité antinatriférique traverse une
membrane permsélective dont le poids moléculaire critique est
de 500. La chromatographie sur colonne de Séphadex GlO
localise l'activité antinatriférique a une seule fraction dont Ic
poids moléculaire est inférieur a 700. La méme fraction qui
inhibe le SCC determine une augmentation de l'excrétion du
sodium et du debit urinaire chez des rats partiellement néphrec-
tomisés subissant une diurése aqueuse maximale. Ces résultats
indiquent que Ic plasma des chiens ayant subi une expansion
contient un facteur humoral dont le poids moléculaire est
inférieur a 500 t 700, qu inhibe le transport de sodium in vitro et
determine une natriurése in vivo. Ce facteur pourrait moduler
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l'excrétion rCnale du sodium dans certaines circonstances
physiologiques.
Investigating the hypothesis that renal sodium
excretion might be partly controlled by one or more
natriuretic hormones, we have recently reported that
plasma of volume-expanded dogs contains an ultra-
filterable inhibitor of toad bladder sodium transport
[1]. The inhibitory activity was found in dogs which
had been acutely expanded with a saline solution and
in dogs chronically expanded as a result of either
spontaneous or mineralocorticoid-induced retention of
dietary sodium [2, 3]. These findings suggested the
transport inhibitor might modulate renal sodium
excretion in response to changes in the volume of
extracellular fluid (ECF).
The present investigation was directed toward the
following problems. First, we wanted to explore
further the relationship between changes in ECF
volume and the presence in plasma of the transport
inhibitor. Accordingly, we determined whether the
activity was present in dogs acutely volume-depleted by
the administration of a pharmacologic diuretic agent.
Second, because of the apparent low molecular weight
of the inhibitory activity, gel chromatography was
performed to gain more information about molecular
weight and to demonstrate that the activity could be
separated from the ionic constituents of plasma.
Third, if the biologic activity which inhibits toad
bladder sodium transport is a natriuretic hormone, it
must be shown to have natriuretic activity in vivo.
Therefore, the chromatographic fraction of plasma
which inhibited sodium transport was tested for
effects on renal sodium excretion in the rat. Finally, to
determine whether the transport inhibitor might
affect sodium transport in other anuran membranes,
one series of studies was performed using the in vitro
frog skin.
Transport inhibitory factor in plasma 13
Methods
Female mongrel dogs weighing 15 to 25 kg, allowed
food and water ad libitum, were made hydropenic by
restriction of water for 12 to 18 hours prior to an
experiment. Jugular vein plasma was obtained for
bioassay from three groups of dogs: Group 1. Acute
ECF expansion was produced in 16 dogs as follows.
Anesthesia was induced with pentobarbital sodium
(30 mg/kg), the bladder catheterized and urine speci-
mens collected every 20 minutes. When a steady state
of urine flow had been obtained (60 to 120 mm after
the induction of anesthesia), an intravenous infusion
of 0.9% saline was begun at 25 ml/min for 20 minutes,
followed by constant infusion of 10/mi/mm for the
remainder of the experiment. Seventy-five to 100 ml of
blood was drawn 90 to 120 minutes after saline in-
fusion was begun. Group 2. Acute ECF volume con-
traction was produced in 13 unanesthetized dogs as
follows. The dogs were weighed, given 50 mg of
furosemide orally and placed in a metabolism cage.
When spontaneous voiding was observed, usually three
to four hours after furosemide administration, the
dogs were reweighed, the volume of urine recorded
and 75 to 100 ml of jugular venous blood was ob-
tained. Group 3. Acute volume depletion and expan-
sion was produced in eight anesthetized dogs as
follows. Anesthesia was induced with pentobarbital
sodium (30 mg/kg), and 50 mg of furosemide was
administered intravenously. Urine was collected every
30 mm through an indwelling Foley catheter. Four
hours after furosemide was administered, a jugular
venous blood sample was obtained and the hemato-
crit was measured. An appropriate volume of saline
was then added to dilute the blood 20 to 25%, the
mean degree of dilution occuring during saline
infusion in group 1 dogs (see Results), and the hemato-
crit remeasured. In four dogs acute volume expansion
was then produced in the same manner as in group 1
dogs and a second blood sample obtained for hemato-
crit and bioassay. In four additional dogs, the same
protocol was followed except that in two dogs blood
samples were obtained only after furosemide admini-
stration and in two dogs only after acute volume
expansion.
Blood samples were drawn into heparinized syrin-
ges and the plasma immediately separated at 4°C and
frozen at —4°C until used. Ultrafiltrates of plasma
were prepared with Diaflo® PM-b membranes (mol
wt cutoff, 10,000) and Model 12 ultrafiltration cells
(10 ml volume) from Amicon Corp., Lexington,
Mass., according to methods previously described [4].
Briefly, ultrafiltration was performed at 5°C using 50
pounds per square inch (psi) of nitrogen at a stirring
speed of 1130 to 1170 rpm. Because the transport-
inhibitor was shown to adsorb to the plastic membrane
support supplied by the manufacturer [4], it was
replaced by a stainless steel wire mesh membrane
support.
Ultrafiltrates were tested for their effects on toad
bladder or frog skin potential difference (PD) and
SCC by methods previously described [1]. Toads of
Colombian origin (Bujo marinus) or frogs (Rana
pipiens) were pithed, the bladder or ventral skin
removed and the membranes placed in Ussing-type
chambers which divided them into two halves, each
with an exposed surface area of 3.5 cm2, and then
bathed in amphibian Ringer's solution. Onlymembranes
with SCC greater than 90 samp/3.5 cm2 were used.
When a steady state of PD and SCC was obtained
(less than 5% variation), serosal or inside Ringer's
solution was aspirated and replaced by ultrafiltrate in
one side and fresh Ringer's solution in the other. In
the case of toad bladders, data are expressed as
percent of change in PD and SCC 30 mm after
ultrafiltrates had been placed in contact with the
bladder. In the case of frog skins, changes were calcu-
lated 45 mill after addition of ultrafiltrate. Changes in
PD and SCC were corrected for the percentage of
spontaneous change on the side receiving the fresh
Ringer solution. Assays in which SCC on the control
side changed more than l4% were discarded.
Negative values indicate inhibition of PD and SCC.
Repeated assays were performed on the same bladder
or skin using quarterbiadders or halfskins alternately.
It was assumed that SCC was equivalent to active
mucosal-to-serosal or outside-to-inside sodium trans-
port [5]. It was also assumed that furosemide used in
groups 2 and 3 had negligible effect on the bioassay,
since plasma half-life of the drug is very short [6] and
blood samples were obtained three to four hours after
drug administration. Moreover, since furosemide may
cause SCC inhibition [7], its presence in plasma ultra-
filtrates would have been to minimize the difference
between volume expanded and volume contracted
animals.
Membranes were kept open-circuited with SCC
monitored intermittently. Assays in groups 1 and 2
were performed using a manual device in which zero
potential was estimated visually utilizing a null
detector. Assays for group 3 experiments were per-
formed using an automatic voltage clamp device in
which zero potential was determined electronically.
None of these assays was performed in a double-
blind manner.
In order to provide additional controls for the effects
of dilution of plasma by saline infusion in vivo, two
blood samples of group 3 dogs were diluted in vitro
with isotonic saline prior to separation of the plasma
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as follows. The volume of the blood sample was
measured and its hematocrit determined. An appro-
priate volume of saline was added to dilute the sample
20 to 25%. Then the plasma was separated and handled
in a similar fashion to all other samples in this study.
A study of the molecular weight characteristics of
the biologic activity of plasma was performed as
follows. Ultrafiltrates from dogs in groups I and 2
were prepared directly from plasma with PM-b
membranes and a 4 ml aliquot was tested for its effect
on toad bladder PD and SCC. The remaining ultra-
filtrate was then passed through a membrane (Diaflo
UM-05, mol wt cutoff, 500) and tested for its effects on
PD and SCC.
Column chromatography. Thirty to 50 ml of ultra-
filtrate from each dog was prepared from 10 ml
batches of plasma with PM-l0 membranes. One 5 ml
aliquot was tested for effects on toad bladder PD and
SCC. The remainder was separated into 10 ml aliquots
and lyophilized. The residue was suspended in 3.5 ml
of 7M HCI and applied to a 1 x 100 G-l0 Sephadex
column (Pharmacia, Piscataway, New Jersey), packed
in 0.lM HC1. The sample was eluted with 0.lM HCI
and 3 ml fractions were collected. Void volumes for
each column were determined by high molecular
weight Blue Dextran (Pharmacia). Because of the
tendency for Blue Dextran to absorb to Sephadex [8],
each column was washed with 3 ml of 7 M HC1 after
the void volume had been determined and before the
column was used, This resulted in the elution of some
adsorbed Dextran as indicated by the faintly blue
color of the eluate.
Eluted samples were analyzed for light absorption at
280 m by a spectrophotometer (Perkin-Elmer, Model
124) and for osmolality by freezing point depression.
Three fractions essentially free of osmotically-active
salt were identified (fractions!, 1! and IV, fraction III
being the salt peak) and these were lyophilized,
resuspended in distilled water and lyophilized again to
remove all traces of HC1. Fractions I and 1Y from eight
group 1 dogs and eight group 2 dogs were suspended
in 4 ml of amphibian Ringer's solution and tested for
effect on toad bladder PD and SCC. Since fraction ii
contained a small amount of osmotically-active
material, it was dissolved in 3.5 ml of amphibian
Ringer (osmolality, 220) which resulted in a solution
with a mean osmolality of 285 5,0 mOsm/kg (range,
251 to 307 mOsm/kg). This preparation was then
diluted to 220 mOsm/kg with distilled water and tested
for effects on PD and SCC. Eleven fraction 11 samples
prepared in this way were analyzed for sodium,
potassium, chloride, phosphorus and calcium con-
centrations by methods previously described [1].
Twelve fraction II samples obtained from eight
group 1 dogs and 12 fraction 11 samples obtained from
ten group 2 dogs were tested for their effects on the
rate of sodium excretion in the rat. The residue of each
sample prepared as described above was kept at
—4C until the day of the assay, at which time the
residue was dissolved in 0.5 ml of distilled water,
yielding a mean osmolality of 278 5.9 mOsm/kg
(range, 236 to 309 mOsm/kg). The injected fraction
was equivalent to 10 ml of plasma ultrafiltrate.
Rat assay. Female Sprague-Dawley rats weighing
170 to 200 g were subjected to partial nephrectomy by
a method previously described [9]. Animals were kept
in individual cages and allowed standard laboratory
chow and tap water ad libitum.
On the morning of the experiment, the rats were
lightly anesthetized with ether and the bladder was
catheterized with polyethylene tubing (PE 160) exter-
nally and secured with a suture. The external jugular
vein was cannulated with a polyethylene tube (PE 90)
and the rat was placed in a restraining cage and allowed
to wake up. This procedure usually required approxi-
mately 20 to 30 mm. The legs of the rat were extended
through holes in the bottom of the cage and were
lightly restrained.
A steady-state, sustained, maximum water diuresis
was obtained in the rats by the following procedure,
which was developed during a series of preliminary
experiments. Infusion of 5% dextrose in water was
begun through the jugular venous cannula by means of
a roller pump (Holter, Model RL 155) at 50 1d/min.
Urine was collected directly into 5 ml graduated
cylinders with complete bladder emptying accom-
plished by suprapubic massage. Urine formation
began 40 to 60 mm after starting the infusion, and
within 60 to 100 mm urine flow rate (V) invariably
exceeded the infusion rate. When this occurred, the
glucose infusion was adjusted upward to exactly
match V, and this procedure was continued as V
progressively rose and leveled off at a steady state in
the range of 90 to 135 d/min. Urine was collected at
10-mm intervals during the period of rising urine
flows and at 20-mm intervals when the steady state
was reached. Water diuresis with urine osmolalities of
80 to 170 mOsm/kg and sodium excretion (UNaV)
from 0.20 to 1.41 Eq/min was obtained in this way.
Animals which did not attain a V of at least 95 1t1/min
within one to two hours after the glucose infusion was
started were found to be severely antinatriuretic, with
UNaV less than 0.20 sEq/min, and were discarded.
Animals in which V rose or fell continuously or in
which V varied by more than l0 from period to
period were not used. When V was constant for four
20-mm periods, 0.5 ml samples of fraction 11 were
injected through the jugular venous catheter at a rate
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of 100 to 150 d/min. Fraction 11 from group 1
(saline-loaded) dogs were designated "uS" and from
group 2 (furosemide-treated), "hF." Urine collected
at 20-mm intervals for 160 mm following the sample
injection was analyzed for sodium concentration by
flame photometry and for osmolality by freezing
point depression.
Statistical analyses were performed by Student's t
test on the Emory University computer (Univac 7)
using programs prepared by the Emory University
Department of Biometry.
Results
The data in Table I summarize the effect of plasma
ultrafiltrates on toad bladder PD and SCC. Using
ultrafiltrates prepared with PM-b membranes directly
from plasma of 16 group 1 dogs, PD was inhibited by
a mean of I6.5±2.2% (mean±sEM) and SCC by a
mean of 25 3.1%. The mean spontaneous change in
the quarterbladder receiving fresh Ringer's solution in
this group of assays was 0± l.2 for PD and 1 l.3%
for SCC. In contrast, ultrafiltrates prepared in a similar
manner from plasma of 13 group 2 dogs caused a
mean change in PD of 2± l.5% and in SCC of 3±
l.7%. The mean spontaneous change in the control
quarterbiadder in these assays was I 1.1 % for PD
and 2 0.9% for SCC. The difference between the
effect of ultrafiltrates on PD and SCC from groups 1
and 2 is highly significant (P< 0.0001),
In group 2 dogs, furosemide administration caused
an acute weight loss of 0.6 0.04 kg and a measured
urine volume after furosemide administration of
489 42 ml. The mean hematocrit value after saline
administration was 41 2 (group 1 dogs) and after
furosemide administration, 53 0.8 (group 2 dogs).
Thus, blood of group 1 dogs was approximately 23%
diluted compared to blood of group 2 dogs. To test
the possibility that the SCC inhibition observed in
group 1 dogs might be due to some nonspecific effect
of this dilution, the blood of two of the group 2 dogs
was diluted 20 to 25% in vitro prior to separation of
Table 1. Effect of ultrafiltrates of dog plasma on toad bladder sodium transport
Expanded dogs (group 1) Contracted dogs (group 2)
Membrane Membrane
PMl0' UM05b PM-10° UM-050
No. PD,% SCC,% PD,% SCC,% No. PD,% SCC,% PD,% SCC,%
I
2
3
4
5
6
7
8
9
10
II
12
13
14
15
16
—15 —33
—15 —2
—9 —17
—2 —6
—23 —27
—19 —50
—14 —17
—22 —30
—20 —26
— 5 —13
—15 —33
—25 —29
—32 —42
—10 —26
—30 —30
—18 —21
—16 —45
—16 —22
—12 —22
—19 —29
—13 —18
—4 —18
—11 —26
—45 —45
—23 —40
—14 —26
1
2
3
4
5
6
7
8
9°
10
11
12
13°
—8 —7
+3 +7
0 +6
+12 +11
+12 +16
+2 +2
0 —2
+4 +1
+ 2 + 5
— I —
+ 4 + 3
+ 2 + 5
— 2 — 4
—7 —13
—3 —2
0 —l
—10 —5
0 — 2
+3 +3
—2 —2
+9 +5
Mean
SEM
P(1)0
P(2)°
—16.5 —25
2.2 3.1
<0.0001 <0.0001
—17 —29
3.5 3.3
>0.2 >0.2
P(3)
2 3
1.5 1.7
— 1 — 2
2.1 1.9
>0.1 >0.05
° PM-10=Diaflo® (Amicon Corp.) membrane with mob wt cutoff 10,000.
UM-05 =Diaflo® membrane with mol wt cutoff 500.
° Blood diluted with saline prior to ultrafiltration (see Methods).
d P(1) =Significance of difference between expanded and contracted dogs, PM-10 ultrafiltrates.
P(2)= Significance of difference between ten paired samples of PM-JO vs UM-05 ultrafiltrates, expanded dogs
(paired t test).
P(3) = Significance of difference between eight paired samples, PM-b vs UM-05 ultrafiltrates, contracted dogs
(paired t test).
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the plasma. Ultrafiltrates of these samples caused no
significant inhibition of SCC as shown in Table 1.
The molecular weight of inhibitory activity in
plasma of group I was studied by passing aliquots of
10 PM-b ultrafiltrates shown in Table 1 through a
membrane (Diaflo UM-05). The resultant ultrafil-
trates caused a mean change in PD of —17 3.5% and
in SCC of —29±3.3, a result which is not signifi-
cantly different (P>0.2) from paired samples of
PM-lO ultrafiltrates.
Inspection of the data in Table I shows that in two
group I dogs (Nos. 2 and 4) PM-b ultrafiltrates
caused a change in SCC of only —2% and —6,
respectively. However, paired samples of these ultra-
filtrates passed through UM-05 membranes caused a
—22 and —29% change in SCC. These results
suggested that plasma of some dogs might contain a
humoral factor with a molecular weight greater than
500 which antagonized the effect of the inhibitor on
toad bladder sodium transport. To test the possibility
that the absence of inhibitory activity in volume-
contracted dogs might be due to the presence of this
postulated antagonist, paired samples of eight PM-lO
ultrafiltrates of group 2 dogs were assayed following
passage through a UM-05 membrane. As shown in
Table I, these UM-05 ultrafiltrates caused a mean
change in PD of —l±2% and in SCC of —2±2%,
which is not significantly different from zero or from
the PM-l0 membrane ultrafiltrates (P> 0.05).
To study further the possible effects of dilution in
volume-expanded dogs and to rule out the possibility
that pentobarbital anesthesia might be responsible for
the differences between group I and 2 dogs, the results
in Table 2 were obtained. In these studies, frog skins
were used in the bioassay for sodium transport inhi-
bition. Furosemide administration caused a cumula-
tive urine volume of 392 33 ml in four hours. Blood
drawn four hours after furosemide administration
and diluted 20 in vitro caused a mean change in PD
of —5±2.l and in SCC of —l0±1.6%. in con-
trast blood obtained two hours after saline infusion,
with the same hematocrit value as the contracted
samples (P>0.5), caused a mean change in PD of
—l3±3.5% and in SCC of —28±2.5. The dif-
ference in SCC between the two groups is highly
significant (P <0.0001).
Column chromatography. Column chromatography
of plasma ultrafiltrates gave a reproducible pattern
which is shown in Fig. 1. Using ultraviolet light absorp-
tion at 280 rns, three salt-free fractions were identified
and are labeled 1, II and IV, fraction Ill being the salt
peak. Fraction I appears immediately after the void
volume; fraction 11, immediately ahead of the salt
peak; and fraction IV, just after the salt peak. The
appearance of these fractions was the same, whether
the ultrafiltrate was prepared from a group 1 or group
2 dog.
The effects of these fractions on toad bladder PD
and SCC are shown in Table 3. Fraction 11 from group
1 dogs (uS) caused a —22 3.5% change in PD and a
—33±2.4% change in SCC. The same fraction from
group 2 dogs (hF) caused a mean change in PD of 0
Table 2. Effect of plasma ultrafiltrates from group 3 dogs on frog skin potential difference
(PD) and short circuit current (SCC)°
Dog Contracted Expanded
Hematocrit, PD,% SCC,% Hematocrit, PD,% SCC,%
vols 0/ vols %
1 37
38
—7 —6 36 —5 —18
2° —12 —16 36 —10 —25
3° 42 + 3 —12 35 —18 —36
4° 33 — 8 —11 39 —15 —30
5° 39 — 3 — 8 40 —26 —30
60 35 —5 —6 33 ---3 —31
Mean 37 — 5 —10 36.5 —13 —28
SCM 1.3 2.1 1.6 1.1 3.5 2.5P >0.5 >0.05 <0.0001
0 Studies were performed with UM-05 membrane ultrafiltrates. Contracted blood samples
were diluted 20% with saline in vitro prior to separation of plasma (see Methods).
0 Contracted and expanded samples obtained from the same dog.
° Contracted and expanded samples obtained from different dogs subjected to the same
protocol.dP=significance of difference between contracted and expanded groups.
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o 3°/ and in SCC of 1 3%, a highly significant dif-
Osmolality ference (P <0.0001). The effect of fraction hF and of
_
5000 all other fractions on PD and SCC was not signifi-
cantly different from zero. The pattern of inhibition of
SCC by fraction uS was similar in all respects to that
found with simple ultrafiltrates of plasma from volume-
expanded dogs [1].
To ascertain whether the different effects of groups
uS and hF might be secondary to some difference in
ionic composition, six samples of uS and five of lIE
were analyzed for Na, K, Cl, Ca and P concentrations
and pH. The results in Table 4 show no significant
difference between the two groups with regard to
these ionic constituents.
Rat bioassay. A typical experiment showing the
effect of intravenous injection of fraction ITS on UNaY
in the partially nephrectomized rat is shown in Fig. 2.
During a control period of 80 mm, UNaV was constant
at approximately 1.0 tEq/min. Following extract
injection, natriuresis began immediately, peaked in the
second and third 20-mm period after injection at
3.23 Eq/min and returned to baseline level 160 mm
after injection. The increment in sodium excretion
above the baseline for the entire 160-mm period
(zX UNaV) was 161 Eq for this experiment. The
effects of fractions ITS and hF on UNaV in partially
nephrectomized rats are shown in Table 3. Mean
baseline sodium excretion in the two groups was 0.76
0.10 Eq/min and 0.58 0.06 tEq, respectively (P>
0.1). The change in UNaV which occurred after the
extract injection is shown in two ways. Peak UNaV is
Table 3. Effect of Sephadex G-10 fractions of dog plasma ultrafiltrates on toad bladder sodium transport
Expanded dogs (group 1) Contracted dogs (group 2)
Experiment
No.
Fraction Experiment
No.
Fraction
IS uS IVS IF hF IVF
PD,% SCC.% PD,% SCC,°/ PD,% SCC,% PD,°/ SCC,% PD,% SCC,% PD,% SCC,%
I — 5 + 8 —15 —30 — 2 +1 1 —4 +4 + 1 —12 0 —8
2 +3 +2 —26 —42 —4 —4 2 —2 —3 —2 —5 —4 —4
3 +23 — 8 —23 —34 +15 +7 3 —6 +4 +10 +19 +3 —l4 + 3 + 5 —13 —21 + 1 —1 4 +2 +4 —12 + 1 +4 +1
5 + 6 + 1 —22 —36 + 1 0 5 —2 +4 —9 —2
6
—9 —2 —10 —26 +13 —2 6 +2 +6 +3
7 +6 +1 —41 —34 +2 +2 7 +9 +1
8 +5 +10 —29 —38 —2 +3 8 +5 +4 —2 +3 +7 +1
Mean + 4 + 1 —22 —33 + 3 +1 Mean —1 +2 0 + 1 +2 —2
SaM 3.4 1.8 3.5 2.4 2.5 1.2 SaM 1.6 1.1 2.8 3.1 1.9 1.9
P(l) >0.5 <0.0005 <0.0001 >0.1 P(2)b >0.1 >0.5 >1.5
P(1) significance of the difference between mean value for expanded dogs and contracted dogs.
b(2) =significance of the difference between mean value and zero.
I II Ill IV
4000
S
OD
280 m1
0.6
0.4
35 45 55 65 75 85
Elution Volume
Fig. 1. Elution profile of dog plasma ultraflitrate on 1 >< 100 cm
column of G-10 Sephadex. Ordinate is optical density (OD) at
280 ms on left and total osmolality on right.
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Table 4. Electrolyte composition of column fraction lE prepared
for toad bladder assay
Fractiona
pb
ITS
(N= 6)
IIF
(N= 5)
Na, mEg/liter 111±1.8 110±0.7 >0.8
K, mEg/liter 3.1 0.05 3.1 0.02 >0.9
Cl, mEq/liter 97± 1.4 96±0.7 >0.6
Ca, mmoles/liter 3.1±0.15 3.6±0.25 >0.1
P, mmoles/liter 1.4±0.65 1.4±0.5 >0.8
pH° 7.38±0.3 7.40±0.2 >0.5
bladderFractions were analyzed after preparation for toad
assay as described in Methods.
P= significance of difference between fractions uS and LIF.
pH was obtained on samples gassed with 97% 02 and 3%
Co2.
UNaV
Eq/min
Control
Mean
Fig. 2. Effect of injection of column fraction from plasma of
saline.loaded dog on sodium excretion in the partially nephrec-
tomized rat. A UNV is the cumulative difference between
sodium excretion during an 80-mm control period and during
a 160-mm period after extract injection.
the highest rate observed during any one of the first
three 20-mm periods following the injection. Peak
UNaV compared to baseline control was significantly
different in both groups (P.<0.00l for group uS and
P <0.05 for group 1ff). However, the pesk value in
group ITS of 2.05 0.29 Eq/min was significantly
higher than the value of 0.74 0.11 Eq/min in group
hF (P <0.0005). In addition, the total increment in
sodium excretion with respect to the steady state
baseline (Li UNaV) is shown. This value was 107
Eq in rats receiving fraction ITS and 1 7 .tEq in
rats receiving fraction hF (P<0.000l). The value in
fraction hF was not significantly different from zero.
Thus, in the control group a small but significant rise
in UNaV occurred transiently following the extract
injection. However, this was followed by a small
decrease so that no net change in UNaV occurred
during the 160 mm following the extract infusion. In
group hIS UNaV rose immediately after extract in-
jection to a value higher than in group hF and sub-
sided over a 160-mm period resulting in a mean net
increase in sodium excretion of 107 REq.
The effect of extract injections on V was also dif-
ferent in the two groups, as summarized in Table 4.
Mean V during the control period was 108 3.4 .il/
mm and 109 4.0 tl/min in groups ITS and hF,
respectively (P>.0.5). In group ITS V rose significantly
in the first four postinjection periods, which corre-
spond to the periods when the largest natriuresis
occurred (Fig. 2). In group hF no significant rise in V
occurred immediately after extract injection and it
became significantly depressed during the fourth
20-mm period. In group uS, V fell significantly only in
the eighth postinjection period.
Discussion
Despite much investigation, the possible existence of
a natriuretic hormone has remained highly controver-
sial. However, recent studies in a number of labora-
tories employing many different approaches have
supported the concept that one or more humoral
factors other than aldosterone may play a role in
regulating the renal excretion of sodium. Several
groups have performed cross circulation studies, in
which the findings are consistent with the presence of a
humoral natriuretic factor in plasma of volume-
expanded subjects [10—13]. Administration of extracts
of plasma and urine from natriuretic subjects have
been shown to inhibit transport of sodium in in vitro
systems such as anuran membranes and isolated renal
tubules [14—16]. Other studies have shown that extracts
of plasma and urine of volume-expanded subjects have
natriuretic effects when administered to assay animals
[14, 17—20]. In addition, injection of saline into the
third cerebral ventricle results in natriuresis, supporting
the existence of a neurohumoral natriuretic system
[21—23]. Finally, many known hormonal substances
such as a-melanocyte-stimulating hormone (MSH)
[24], vasopressin and oxytocin [25, 26], calcitonin [27],
glucagon [28], prostaglandins [29] and others, whose
major physiologic roles do not involve sodium metab-
olism, have been shown to promote natriuresis under
some conditions. It has been suggested that several of
these hormones might play a role in the physiologic
regulation of renal sodium excretion [24, 29].
We demonstrated previously that dialysates and
ultrafiltrates of volume-expanded dogs inhibited
sodium transport by the isolated urinary bladder of
Mm
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the toad [1]. When these earlier studies were performed,
we were unaware of some technical problems associated
with the ultrafiltration process which might have
influenced our data [4], such as concentration polar-
ization effects on membrane permeability and the
absorptive properties of the plastic membrane support.
The first group of studies described in this report
demonstrates that by using an improved technique of
ultrafiltration we can reproducibly demonstrate an
inhibitor of sodium transport in plasma of dogs
acutely expanded with saline, which is not detected, or
detected only minimally, in acutely volume-depleted
dogs. In addition, the present studies demonstrating
inhibition of frog skin sodium transport by plasma of
volume-expanded dogs extends our observations to a
second anuran membrane.
In our original studies we found that the transport
inhibitor was dialyzable across cellophane membranes,
suggesting a very low molecular weight [1]. The present
studies show that the inhibitory activity passes
readily through a membrane with a molecular weight
cutoff of 500 (Diaflo UM-05). Thus, the upper limit of
the molecular weight of the inhibitory activity is
approximately 500, which is in the range of a sub-
stance that could be readily dialyzed through cello-
phane [30].
The column chromatography studies were performed
to separate the inhibitory activity from the ionic com-
ponents of plasma and to obtain additional informa-
tion concerning its molecular weight. Our initial
attempts showed that separation of ionic constituents
from those with significant ultraviolet light absorbancy
at 280 m could not be achieved on G-l0 Sephadex
with mild conditions [2], probably due to the inter-
ference of adsorption phenomena [31]. We therefore
applied progressively stronger conditions and obtained
separation by suspending the lyophilized plasma ultra-
filtrate in 7M hydrochloric acid. Such strong conditions
are known to dissolve Sephadex [32] and, therefore,
this technique has limited applicability because of
short column life.
Results of these studies show that the transport
inhibitor was confined to one fraction which appeared
immediately before the salt peak and was associated
with the major peak of absorbancy, 280 mt. The loca-
tion of this fraction indicates that its components were
retarded by the gel, suggesting a molecular weight
range less than the exclusion limit of G-10 Sephadex of
700. Although location of the inhibitor in the chro-
matogram supports the estimate of the upper limit of
its molecular weight obtained by the ultrafiltration
studies, this conclusion must be tentative since we
have not studied the possible effects of 7M HCI on the
exclusion limit of G-10 Sephadex and the possible
role of adsorption phenomena has not been evaluated.
If this conclusion is to be validated, it will be necessary
to undertake further studies using this technique and
employing a column calibrated with substances of
known molecular weight.
Our studies of the effect of plasma extract adminis-
tration on sodium excretion in the rat were designed
with several problems in mind. First, the amount of
inhibitory activity in the extract employed represented
Table 5. Effect of Sephadex fraction II on sodium excre-
tion in the partially nephrectomized rata
Experiment
No.
Control,
iEq/min
Peak,
pEqlmin i.Eq
Fraction uS
1
2
3
4
5
6
7
8
9
10
11
12
0.46
1.01
0.86
1.0
0.3
0.80
1.20
0.64
1.41
0.70
0.57
0.20
2.21
3.23
1.37
2.88
1.37
2.97
2.23
1.08
2.61
3.36
0.80
0.50
224
161
37
158
119
200
92
64
26
150
7
44
Mean
SEM
0.76
0.10
2.05
0.29
107
21
P(1)5 <0001
Fraction hF
1
2
3
4
5
6
7
8
9
10
11
12
0.52
0.69
0.70
0.82
0.82
0.40
0.32
0.54
0.95
0.38
0.48
0.37
0.62
0.65
0.62
1.29
1.21
0.34
0.46
0.56
1.28
0.31
1.13
0.44
—10
—33
—32
10
48
—10
10
—6
36
—23
9
12
Mean
SEM
0.58
0.06
0.74
0.11
1
7
P(l)b
P(2)° >0.1
<0.05
<0.0005 <0.0001
a Peak=highest value observed during any one of the
first three 20-mm periods after extract injection. A =
total increment or decrement in sodium excretion com-
pared to steady state control value for 180 mm after
extract injection.
P(1) = significance of difference between control and
peak values (paired t test).
o P(2)=significance of difference between mean values
for group lIS vs group hF.
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at most that amount contained in 10 ml of plasma.
Assuming that the transport inhibitor was distributed
in the extracellular fluid of the assay animal, the maxi-
mum plasma concentration of the inhibitor which
could be achieved in a 200 g rat would be about 25%
of that present in the dog, Because of this problem we
wished to have a preparation that would be very sensi-
tive to natriuretic stimuli. Accordingly, we performed
the studies in an animal with a reduced nephron popu-
lation. Such animals respond to some natriuretic
stimuli with a greater increase in fractional sodium
excretion than subjects with a normal nephron
population exposed to the same natriuretic stimulus
[33—36].
The second problem which influenced the design of
our studies concerned possible sites of action in the
nephron. If the transport inhibitor were to inhibit only
proximal tubular sodium reabsorption, it is possible
that significant natriuresis would not occur due to in-
creased sodium reabsorption distally [37]. However, if
the studies were performed in animals undergoing a
maximum water diuresis, any inhibition in proximal
sodium reabsorption would be detected as an in-
creased urine volume, whether natriuresis occurred
or not [38]. Furthermore, observations of urine
osmolality during maximum water diuresis would
provide evidence of any inhibitory effect on the loop of
Henle, If injection of the extract during a maximum
water diuresis were associated with an increase in
urine flow and a rise in urine osmolality, these in-
creases would indicate an inhibitory effect on the
diluting segment of the distal tubule.
The results summarized in Table 5 indicate that a
significant natriuretic effect was produced by adminis-
tration of plasma extract from saline-expanded dogs.
This effect became apparent within the first 20 mm,
with a peak effect occurring within the first hour after
injection. Natriuresis subsided gradually over a
period of 160 mm after the extract injection.
The data in Table 6 show that natriuresis was
accompanied by an increase in urine flow, which
followed the same time course as the natriuretic effect.
Increased urine flow in association with natriuresis in
animals undergoing a maximum water diuresis could
have been due to 1) an increased delivery of sodium
and water to the loop of Henle secondary to an increase
in glomerular filtration rate or a decrease in proximal
sodium reabsorption, or both; or 2) a decrease in the
rate of sodium reabsorption in the ascending limb of
the loop of Henle. Data were not obtained in these
studies to distinguish between these two possibilities.
Although the mechanism of the natriuresis produced
by administration of extracts of plasma of volume-
expanded dogs is not clearly defined by these experi-
ments, the fact that the same fraction which caused
inhibition of sodium transport in the toad bladder also
caused natriuresis suggests that the latter was due to
inhibition of transepithelial tubular sodium transport.
The possibility that natriuresis was due, at least in
part, to an increase in glomerular filtration rate or an
Table 6. Effect of Sephadex fraction II on urine flow in the partially nephrectomized rata
Fraction
ItS
b
!L//,fljfl
P(1)' P(2) hF
Va
jjjmin
P(l)C
Control 108 >0.5 109±4.0
Period after
injection
1 123.5±4.8 <0.001 <0.02 107±4.3 >0.5
2 123 <0.001 <0.05 105±7.5 >0.5
3 121
4
101
6 <0.05
>0.5 <0.02
>0.5 91 6.0 <0.01
a Data are means SEM (W=12). Control values are the mean of steady state urine flow prior to extract
injection.' V=urine flow rate.
P(1)=significancc of difference between control value and value after injection (paired t test) within
each group.dP(2)=significance of difference between the value for group uS and the value for group HF.
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increase or redistribution in renal blood flow was not
ruled out.
Whatever the mechanism, the results of these studies
indicate that plasma of volume-expanded dogs con-
tains, in addition to a sodium transport inhibitory
activity, a natriuretic activity, which is not detectable
in plasma of volume-contracted dogs. Furthermore,
both of these activities are present in the same chro-
matographic fraction, suggesting that both are due to
the same substance or substances.
These data provide additional support for the con-
cept that natriuresis during volume expansion in dogs
results in part from a circulating natriuretic factor.
However, this interpretation must be made with
caution since the assay animals were rats with a
reduced number of nephrons. it remains to be shown
that the biologically active substance can induce
natriuresis in an animal with two normal kidneys. in
addition, the natriuretic effect was relatively modest
compared to that seen in rats undergoing natriuresis
during the infusion of isotonic saline [39]. There might
be two reasons for this. First, the alterations in pen-
tubular physical factors caused by saline infusion [40],
which might augment a hormone-induced natniuresis,
would not be present during the injection of the hor-
mone alone. Second, as we noted earlier, blood levels
of the natriuretic factor achieved in the assay rats were
only a fraction of those present in the donor dog and
it could be that extracts of plasma containing more
natriuretic material would cause larger natriuresis.
This possibility is presently under investigation.
The results of the present studies are of interest in
relation to reports from other laboratories. Ultra-
filterable natriuretic and antinatriferic activity in the
plasma of diuretic subjects has been reported by
Cort et al [14] and, recently, by Kramer and Kruck
[41]. it is not yet possible to determine whether the
activity demonstrated in the present studies is due to
the same substance or substances reported by these
investigators. However, the molecular weight of the
activity observed in the present studies indicates that it
is a different substance from the natriuretic material
in the urine of volume-expanded subjects reported by
Sealey, Kirshman and Laragh [18] and others [17, 19,
20]. For the same reason, it seems unlikely that this
activity is due to any of the known humoral factors
which cause natriuresis, such as vasopressin and its
analogues, calcitonin, glucagon or a-MSH, since all of
these substances have a molecular weight greater than
1000.
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